1. Home
  2. AMPH vs CMRE Comparison

AMPH vs CMRE Comparison

Compare AMPH & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CMRE
  • Stock Information
  • Founded
  • AMPH 1996
  • CMRE 1974
  • Country
  • AMPH United States
  • CMRE Monaco
  • Employees
  • AMPH N/A
  • CMRE N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CMRE Marine Transportation
  • Sector
  • AMPH Health Care
  • CMRE Consumer Discretionary
  • Exchange
  • AMPH Nasdaq
  • CMRE Nasdaq
  • Market Cap
  • AMPH 1.6B
  • CMRE 1.3B
  • IPO Year
  • AMPH 2014
  • CMRE 2010
  • Fundamental
  • Price
  • AMPH $31.28
  • CMRE $10.48
  • Analyst Decision
  • AMPH Buy
  • CMRE Hold
  • Analyst Count
  • AMPH 4
  • CMRE 2
  • Target Price
  • AMPH $50.33
  • CMRE $13.50
  • AVG Volume (30 Days)
  • AMPH 479.2K
  • CMRE 456.1K
  • Earning Date
  • AMPH 03-03-2025
  • CMRE 02-05-2025
  • Dividend Yield
  • AMPH N/A
  • CMRE 4.39%
  • EPS Growth
  • AMPH 17.38
  • CMRE N/A
  • EPS
  • AMPH 3.01
  • CMRE 2.44
  • Revenue
  • AMPH $723,549,000.00
  • CMRE $2,083,893,999.00
  • Revenue This Year
  • AMPH $16.22
  • CMRE N/A
  • Revenue Next Year
  • AMPH $4.27
  • CMRE N/A
  • P/E Ratio
  • AMPH $10.39
  • CMRE $4.30
  • Revenue Growth
  • AMPH 20.33
  • CMRE 37.88
  • 52 Week Low
  • AMPH $30.34
  • CMRE $10.33
  • 52 Week High
  • AMPH $56.38
  • CMRE $17.58
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 25.63
  • CMRE 30.41
  • Support Level
  • AMPH $30.34
  • CMRE $10.37
  • Resistance Level
  • AMPH $32.40
  • CMRE $10.85
  • Average True Range (ATR)
  • AMPH 0.87
  • CMRE 0.32
  • MACD
  • AMPH 0.01
  • CMRE 0.01
  • Stochastic Oscillator
  • AMPH 23.21
  • CMRE 8.79

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: